Hypothesis

We propose that intermittent, low‑dose expression of the Yamanaka factors (OSKM) in mature excitatory neurons reduces perineuronal net (PNN) deposition, thereby reversing age‑related synaptic rigidity without inducing dedifferentiation or tumorigenicity.

Mechanistic Rationale

Aging hippocampi show increased PNNs around parvalbumin‑positive interneurons, which limit long‑term potentiation (LTP) and cognitive flexibility [2]. PNNs are composed of chondroitin sulfate proteoglycans (CSPGs) such as neurocan and brevican, whose synthesis is driven by hyaluronan synthase 2 (Has2) and chondroitin polymerizing enzymes [3]. Recent work shows that transient OSKM activation opens chromatin at loci encoding microRNA‑132 (miR‑132) and matrix metalloproteinase‑9 (MMP9) [1]. miR‑132 directly represses Has2 and neurocan transcripts, while MMP9 degrades existing CSPG cross‑links. We hypothesize that cyclic OSKM pulses induce a temporary epigenomic state that up‑regulates miR‑132 and MMP9, tipping the balance toward PNN degradation and reduced de novo CSPG production. Because the exposure is brief and intermittent, neurons retain their identity, avoiding the pluripotent state associated with continuous factor expression.

Experimental Design

Animal model: 20‑month‑old C57BL/6 mice (aged) expressing a doxycycline‑inducible OSKM cassette under the CaMKIIα promoter (excitatory neuron‑specific).

Intervention: Mice receive doxycycline for 24 h every 7 days (cyclic) over 8 weeks. Control groups: (a) aged mice with constant doxycycline (continuous OSKM), (b) aged mice receiving vehicle, (c) young adult mice (3 months) receiving vehicle.

Readouts:

• Histochemistry: Wisteria floribunda agglutinin (WFA) staining to quantify PNN density in CA2 and CA1; immunostaining for parvalbumin.
• Synaptic plasticity: ex vivo hippocampal slice electrophysiology measuring LTP magnitude after theta‑burst stimulation.
• Molecular: qPCR and western blot for miR‑132, Has2, neurocan, MMP9, and BDNF/trkB signaling.
• Behavior: pattern separation task (spatial location discrimination) and reversal learning in a water maze.

Statistical plan: Two‑way ANOVA (treatment × age) with post‑hoc Tukey; n = 10 per group to achieve 80 % power for detecting a 20 % change in WFA area.

Predictions and Falsifiability

If cyclic OSKM expression restores plasticity, we expect:

• A significant reduction (~30‑40 %) in WFA‑positive area relative to vehicle‑treated aged mice, comparable to young adult levels.
• Enhanced LTP (≥1.5‑fold increase) and restored BDNF/trkB signaling.
• Improved performance on pattern separation and reversal learning tasks.
• Continuous OSKM should produce similar PNN reduction but with detectable ectopic expression of pluripotency markers (e.g., Oct4) and increased tumorigenic risk, confirming that intermittency is critical for safety.

Falsification: If cyclic OSKM fails to lower PNN density, does not improve LTP or behavior, or if PNN reduction occurs without accompanying molecular changes (miR‑132/MMP9), the hypothesis would be refuted. Likewise, if continuous OSKM yields no PNN reduction despite pluripotency marker expression, the proposed mechanistic link would be challenged.

By targeting the epigenetic‑extracellular matrix axis that underlies over‑consolidation, this approach shifts the goal from restoring lost components to actively loosening a overly stable matrix, directly testing the idea that cognitive aging stems from excessive confidence in existing neural maps.